The Florida Pediatric NCORP renewal application for grant# UG1CA189973 to continue participation in the NCI Community Oncology Research Program.

佛罗里达儿科 NCORP 续展拨款申请

基本信息

项目摘要

Project Summary The Florida Pediatric NCORP will be a consortium of five Florida hospitals. The NCORP will geographically cover a large portion of Florida and will provide pediatric oncology care to the largest population centers in Florida, the third largest state in the country. The hospitals are located in Ft. Myers, Hollywood, Orlando, and two sites inTampa, as well as the Central Office. Over a 34 year period the Florida Pediatric CCOP and now Florida Pediatric NCORP is among the single largest contributor of patients to COG treatment, cancer control, and over the last two years, cancer care delivery studies. The CCOP and now the NCORP has consistently had outstanding compliance scores and contributes to the administration and science of COG through its members who chair or co-chair research base protocols. The goal of the Florida Pediatric NCORP will be a continuing effort to make available the latest advances in cancer care to patients in Florida through participation in clinical trials and to register the majority of their eligible patients on COG protocols, thereby providing quality care in patients’ home communities. The Florida Pediatric NCORP will provide a unique opportunity to study a geographically-defined population to investigate risk factors, patterns of care, and population- based interventions. The Florida Pediatric NCORP will also maintain a Patient Log which affords the opportunity to ensure the majority of eligible patients are registered on appropriate COG protocols. Over the last grant cycle, the five Florida Pediatric NCORP participating sites have averaged 270 patient registration on COG treament, cancer control, and cancer care delivery protocols, as well as 321 biospeciem. The Florida Pediatric NCORP anticipates increased patient registrations as more COG treatment, cancer control, and cancer care delivery protocols become available. COG quality-control procedures will apply uniformly to the Florida Pediatric NCORP, ensuring compliance with protocols and external review of pathology, radiotherapy, surgery, and chemotherapy.
项目摘要 佛罗里达小儿NCORP将是五家佛罗里达州医院的财团。 NCORP会 在地理上覆盖佛罗里达州的大部分地区,并将为儿科肿瘤学提供护理 佛罗里达州最大的人口中心是该国第三大州。医院是 位于英尺。迈尔斯,好莱坞,奥兰多和两个网站Intampa以及中央办公室。 在34年内 患者对COG治疗,控制癌症控制和最后两个患者的最大贡献者 年,癌症护理提供研究。 CCOP和现在NCORP一直 出色的合规分数并有助于COG的管理和科学 通过其主席或联合主席研究基础协议的成员。佛罗里达的目标 小儿NCORP将继续努力,以取得癌症的最新进展 通过参加临床试验来照顾佛罗里达州的患者,并注册大部分 他们的合格患者在COG方案中,从而在患者家中提供优质的护理 社区。佛罗里达小儿NCORP将为学习一个独特的机会学习 地理定义的人口,以调查危险因素,护理模式和人群 - 基于干预措施。佛罗里达州小儿NCORP还将维护提供的患者日志 确保大多数合格患者在适当COG上注册的机会 协议。在上一个赠款周期中,五个佛罗里达小儿NCORP参与的网站有 在COG宝藏,癌症控制和癌症护理方面平均270例患者注册 协议以及321个生物培训。佛罗里达小儿NCORP预计会增加 患者注册作为更多COG治疗,癌症控制和癌症护理输送方案 可用。 COG质量控制程序将均匀地适用于佛罗里达小儿 NCORP,确保遵守方案和对病理,放疗的外部审查, 手术和化学疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEFFREY P KRISCHER其他文献

JEFFREY P KRISCHER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEFFREY P KRISCHER', 18)}}的其他基金

Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
有限的竞争:在年轻研究中糖尿病的环境决定因素(TEDDY)中继续对受试者进行随访并启动第二个病例对照队列
  • 批准号:
    10398923
  • 财政年份:
    2021
  • 资助金额:
    $ 72.37万
  • 项目类别:
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)
人类基因转移
  • 批准号:
    10403442
  • 财政年份:
    2021
  • 资助金额:
    $ 72.37万
  • 项目类别:
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)
人类基因转移
  • 批准号:
    10179934
  • 财政年份:
    2021
  • 资助金额:
    $ 72.37万
  • 项目类别:
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
有限的竞争:在年轻研究中糖尿病的环境决定因素(TEDDY)中继续对受试者进行随访并启动第二个病例对照队列
  • 批准号:
    10227415
  • 财政年份:
    2021
  • 资助金额:
    $ 72.37万
  • 项目类别:
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)
人类基因转移
  • 批准号:
    10702185
  • 财政年份:
    2021
  • 资助金额:
    $ 72.37万
  • 项目类别:
Follow-up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
青年糖尿病环境决定因素研究(TEDDY)中的受试者跟踪、综合数据分析和病毒抗体测量
  • 批准号:
    10392400
  • 财政年份:
    2020
  • 资助金额:
    $ 72.37万
  • 项目类别:
Follow-up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
青年糖尿病环境决定因素研究(TEDDY)中的受试者跟踪、综合数据分析和病毒抗体测量
  • 批准号:
    10260891
  • 财政年份:
    2020
  • 资助金额:
    $ 72.37万
  • 项目类别:
NIDDK Follow-up on Subjects and Immunological Assessments in The Environmental Determinants of Diabetes In The Young Study (TEDDY) (UC4)
NIDDK 青年糖尿病环境决定因素研究 (TEDDY) (UC4) 中受试者和免疫学评估的后续行动
  • 批准号:
    10088137
  • 财政年份:
    2017
  • 资助金额:
    $ 72.37万
  • 项目类别:
Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)USF: TrialNet UC4-3
1 型糖尿病数据协调中心 TrialNet (UC4)USF:TrialNet UC4-3
  • 批准号:
    9506924
  • 财政年份:
    2017
  • 资助金额:
    $ 72.37万
  • 项目类别:
Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED) - DCC
多中心介入性淋巴管平滑肌瘤病早期疾病试验 (MILED) - DCC
  • 批准号:
    10249943
  • 财政年份:
    2016
  • 资助金额:
    $ 72.37万
  • 项目类别:

相似海外基金

D.R.I.V.E: Developing Research Initiatives through Versatile Oncology Exploration
D.R.I.V.E:通过多功能肿瘤学探索制定研究计划
  • 批准号:
    10892498
  • 财政年份:
    2023
  • 资助金额:
    $ 72.37万
  • 项目类别:
Career Enhancement Core-001
职业提升核心-001
  • 批准号:
    10660385
  • 财政年份:
    2023
  • 资助金额:
    $ 72.37万
  • 项目类别:
Community to Molecular Approaches in Early Screening and Diagnosis to Promote Equitable Outcomes Through the Continuum of Care in Cancer Among Populations of African Ancestry
社区采用分子方法进行早期筛查和诊断,通过对非洲裔人群癌症的持续护理来促进公平结果
  • 批准号:
    10754038
  • 财政年份:
    2023
  • 资助金额:
    $ 72.37万
  • 项目类别:
Development of blood-based methylation biomarkers for CRC risk prediction
开发用于 CRC 风险预测的血液甲基化生物标志物
  • 批准号:
    10712300
  • 财政年份:
    2023
  • 资助金额:
    $ 72.37万
  • 项目类别:
The impact of segregation and the mediating effects of vascular risk on 10-year cognitive and functional outcomes in Black/African American older adults enrolled in the ACTIVE study
隔离的影响以及血管风险对参加 ACTIVE 研究的黑人/非裔美国老年人 10 年认知和功能结果的影响
  • 批准号:
    10791382
  • 财政年份:
    2023
  • 资助金额:
    $ 72.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了